ReviewJapanese journal of radiology2026
Predictive imaging in abdominal oncology: current trends and future directions.
Review in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While the concept of predictive imaging is not entirely new, advanced analytic tools such as radiomics and machine learning have laid the foundation for a new generation of predictive imaging, which goes far beyond what is visible to the human eye. Predictive imaging has emerged as a transformative tool in abdominal oncology, offering the potential to personalize cancer detection and diagnosis, staging, treatment planning, monitoring and prognostication. A growing trend in predictive imaging is the creation of integrated models that combine multimodal imaging data, clinical parameters, genomic and molecular biomarkers. These integrated models can potentially offer superior prognostic capabilities and better risk stratification than traditional models in patients with abdominal cancers. Predictive imaging powered by radiomics and delta radiomics, artificial intelligence, and multimodal data integration is on the way for reshaping abdominal oncology. When current challenges are overcome, it is presumable that predictive imaging will offer powerful, noninvasive means to guide individualized care for patients with abdominal cancers, translating imaging data into actionable clinical insights. The purpose of this article was to provide an overview of the capabilities of predictive imaging in hepatic, pancreatic, colorectal, and gastric cancers.
Indexed as
Identifiers
41165910What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.